Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 1 592.6 INR -0.72% Market Closed
Market Cap: 13.6B INR

Hester Biosciences Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Hester Biosciences Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Hester Biosciences Ltd
NSE:HESTERBIO
Cash from Operating Activities
₹578.7m
CAGR 3-Years
123%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Cash from Operating Activities
₹12m
CAGR 3-Years
130%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Cash from Operating Activities
₹94.9m
CAGR 3-Years
-19%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Cash from Operating Activities
₹41.6B
CAGR 3-Years
53%
CAGR 5-Years
32%
CAGR 10-Years
29%
Panacea Biotec Ltd
NSE:PANACEABIO
Cash from Operating Activities
-₹273.7m
CAGR 3-Years
37%
CAGR 5-Years
2%
CAGR 10-Years
N/A
No Stocks Found

Hester Biosciences Ltd
Glance View

Market Cap
13.5B INR
Industry
Biotechnology

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

HESTERBIO Intrinsic Value
1 149.65 INR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Hester Biosciences Ltd's Cash from Operating Activities?
Cash from Operating Activities
578.7m INR

Based on the financial report for Sep 30, 2025, Hester Biosciences Ltd's Cash from Operating Activities amounts to 578.7m INR.

What is Hester Biosciences Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
7%

Over the last year, the Cash from Operating Activities growth was -13%. The average annual Cash from Operating Activities growth rates for Hester Biosciences Ltd have been 123% over the past three years , 7% over the past five years .

Back to Top